Business Context and Reporting Period
Company: NeoGenomics, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: April 28, 2026
Period Covered: First fiscal quarter of 2026
This filing serves as a notification that the company issued a press release on April 28, 2026, reporting its financial results for the first quarter of 2026. The press release is included as Exhibit 99.1 and is incorporated by reference.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The filing explicitly states that the detailed results for revenue, profit, cash flow, margins, debt, and liquidity are contained within the press release (Exhibit 99.1), which is not included in the input text. Therefore, no specific financial metrics can be extracted from this document alone.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms the issuance of the Q1 2026 results report.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. These elements, if present, would be located in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) to obtain specific Q1 2026 revenue, net income, and cash flow figures.
- Verify the company's guidance for the remainder of fiscal year 2026, which is not present in this summary filing.
- Check for any material changes in debt covenants or liquidity positions detailed in the full press release.
- Confirm the date of the signature (October 28, 2025) versus the report date (April 28, 2026) to ensure understanding of the filing timeline.